Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Representational Photo The exploration of novel peptides for their potential impact on metabolic pathways has been a ...

MADRID — The benefits of semaglutide treatment in reducing kidney disease, cardiovascular, and mortality risks in people with ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...